In another example, tamoxifen, a selective estrogen receptor (ER) modulator used to treat breast cancer, acts as either an ER agonist or antagonist depending on cancer cell types, probably due to the altered relative expressions of coactivators and corepressors [47]. The gene discussed is ESR1; the disease is breast carcinoma.